ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 794

$934K Total Retail Price of All Prescriptions

Rank: 85 out of 794

1,137 Patients Receiving at Least One Drug in Part D
80% Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,137 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$94 was the average price of a prescription from this provider, compared to $254 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
GABAPENTIN 792 637 273 1 3
CARBIDOPA-LEVODOPA 455 389 105 2 1
DONEPEZIL HCL 387 363 97 3 2
LEVETIRACETAM 376 63 55 4 4
CLOPIDOGREL 299 273 72 5 17
PRAMIPEXOLE DIHYDROCHLORIDE 282 225 56 6 11
QUETIAPINE FUMARATE 259 203 68 A 7 15
NAMENDA 228 228 42 8 5
CYMBALTA 225 201 58 9 24
ZOLPIDEM TARTRATE 214 195 51 10 32
LORAZEPAM 212 192 79 B 11 36
CARBIDOPA-LEVODOPA-ENTACAPONE 211 206* 34 12 39
TOPIRAMATE 201 15 28 13 6
ESCITALOPRAM OXALATE 189 184* 43 14 21
OXCARBAZEPINE 180 37 28 15 38
MIRTAZAPINE 176 171* 57 16 44
CARBAMAZEPINE 170 65 31 17 19
LYRICA 167 131 51 18 18
AMITRIPTYLINE HCL 156 106 47 R 19 23
LIDODERM 154 143 36 20 46
TRAZODONE HCL 141 124 35 21 37
EXELON 141 136* 28 21 14
PRIMIDONE 126 108 33 23 16
TRIHEXYPHENIDYL HCL 126 93 35 R 23 75
OLANZAPINE 124 119* 29 A 25 80
AZILECT 118 113* 24 26 12
DIVALPROEX SODIUM ER 117 22 24 27 34
DIVALPROEX SODIUM 112 42 21 28 26
LAMOTRIGINE 106 <11 <11 29 8
PAROXETINE HCL 93 75 26 30 47
VOLTAREN 91 86* 30 31 54
CARBIDOPA-LEVODOPA ER 89 84* 15 32 7
AMLODIPINE BESYLATE 87 71 24 33 56
ROPINIROLE HCL 86 81* 17 34 13
DICLOFENAC SODIUM 84 67 36 35 101
PHENYTOIN SODIUM EXTENDED 82 28 14 36 22
ATORVASTATIN CALCIUM 80 51 20 37 57
MELOXICAM 77 77 30 38 40
VIMPAT 74 <11 <11 39 33
CELEBREX 72 60 17 40 76
ATENOLOL 70 58 15 41 102
PROPRANOLOL HCL 67 53 15 42 27
ALENDRONATE SODIUM 64 64 12 43 119
CLONAZEPAM 63 37 17 B 44 10
CLONIDINE HCL 63 12 14 44 139
RIVASTIGMINE 57 57 16 46 67
RISPERIDONE 55 31 15 A 47 48
FLUOXETINE HCL 54 49* 13 48 70
STALEVO 100 52 47* 14 10 49 219
LEVOTHYROXINE SODIUM 52 <11 <11 49 84
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.